A new deal with major drugmakers, unveiled by U.S. President Donald Trump on Thursday, aims to expand coverage and cut prices for popular weight-loss drugs south of the border.
Stocktwits on MSN
Can Hims & Hers Keep Its GLP-1 Edge After Trump Forces Lilly And Novo To Slash Prices? Wall Street Isn’t Convinced
Citi calls Trump’s GLP-1 pricing deal “less bad than feared,” while Needham warns it could erode Hims’ cost advantage. ・Trump ...
Front Porch Cohousing is enhancing its team with the addition of two strategic advisors. Desiree Kameka Galloway will assume the role of Strategic Advisor for Community Development & Operations, while ...
A White House event led by US President Donald Trump took an unexpected turn when a man standing behind him collapsed during ...
Oz acknowledged obesity isn’t “a deficiency of GLP drugs” but called reducing costs “a belt-and-suspenders approach.” ...
President Donald Trump on Thursday announced deals with Eli Lilly and Novo Nordisk to slash the prices of some of their obesity drugs, ...
Following news that Medicare will expand coverage for GLP-1 medications such as Ozempic, Wegovy, and Mounjaro, MENU ORDER AI is preparing for its App Store debut—timed perfectly to serve the nation's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback